The mechanism of phenotypic sex differentiation

J. D. Wilson, Jim Griffin III, F. W. George

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

For the first 2 months of gestation, there is no difference in the development of male and female embryos. Gonadal differentiation then ensues, and the ovary and testis commence to synthesize their characteristic hormones at approximately the same time. The initial secretion of testosterone by the fetal testis and 17β-estradiol by the fetal ovary appears to be independent of gonadotropin control. If an ovary or no gonad is present, the resulting phenotype is female; thus no gonadal hormones appear to be required for female development. In contrast, two secretions of the fetal testis are responsible for the imposition of the male phenotype. Mullerian regression factor, a poorly characterized peptide hormone, is responsible for suppression of the mullerian ducts, and testosterone accounts for the remainder of male development. The mechanisms by which testosterone causes this differentiative process have been deduced from studies in humans and animals of single gene mutations that interfere with androgen action. Testosterone itself is responsible for virilization of the wolffian ducts into the epididymis, vas deferens, and seminal vesicles, whereas the testosterone metabolite dihydrotestosterone induces the development of the male urethra and external genitalia. Both testosterone and dihydrotestosterone act by combining in the cell cytosol with a high affinity receptor protein that is translocated to the cell nucleus. Chromosomal sex determines gonadal sex, and gonadal sex in turn dictates phenotypic sex.

Original languageEnglish (US)
Pages (from-to)1275-1283
Number of pages9
JournalArthritis and Rheumatism
Volume22
Issue number11
StatePublished - 1979

Fingerprint

Sex Differentiation
Testosterone
Testis
Ovary
Dihydrotestosterone
Wolffian Ducts
Mullerian Ducts
Anti-Mullerian Hormone
Virilism
Gonadal Hormones
Phenotype
Genitalia
Vas Deferens
Peptide Hormones
Seminal Vesicles
Epididymis
Gonads
Urethra
Cell Nucleus
Gonadotropins

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Wilson, J. D., Griffin III, J., & George, F. W. (1979). The mechanism of phenotypic sex differentiation. Arthritis and Rheumatism, 22(11), 1275-1283.

The mechanism of phenotypic sex differentiation. / Wilson, J. D.; Griffin III, Jim; George, F. W.

In: Arthritis and Rheumatism, Vol. 22, No. 11, 1979, p. 1275-1283.

Research output: Contribution to journalArticle

Wilson, JD, Griffin III, J & George, FW 1979, 'The mechanism of phenotypic sex differentiation', Arthritis and Rheumatism, vol. 22, no. 11, pp. 1275-1283.
Wilson, J. D. ; Griffin III, Jim ; George, F. W. / The mechanism of phenotypic sex differentiation. In: Arthritis and Rheumatism. 1979 ; Vol. 22, No. 11. pp. 1275-1283.
@article{f60fef1a5cbe43fe8b26d3ca00916fd2,
title = "The mechanism of phenotypic sex differentiation",
abstract = "For the first 2 months of gestation, there is no difference in the development of male and female embryos. Gonadal differentiation then ensues, and the ovary and testis commence to synthesize their characteristic hormones at approximately the same time. The initial secretion of testosterone by the fetal testis and 17β-estradiol by the fetal ovary appears to be independent of gonadotropin control. If an ovary or no gonad is present, the resulting phenotype is female; thus no gonadal hormones appear to be required for female development. In contrast, two secretions of the fetal testis are responsible for the imposition of the male phenotype. Mullerian regression factor, a poorly characterized peptide hormone, is responsible for suppression of the mullerian ducts, and testosterone accounts for the remainder of male development. The mechanisms by which testosterone causes this differentiative process have been deduced from studies in humans and animals of single gene mutations that interfere with androgen action. Testosterone itself is responsible for virilization of the wolffian ducts into the epididymis, vas deferens, and seminal vesicles, whereas the testosterone metabolite dihydrotestosterone induces the development of the male urethra and external genitalia. Both testosterone and dihydrotestosterone act by combining in the cell cytosol with a high affinity receptor protein that is translocated to the cell nucleus. Chromosomal sex determines gonadal sex, and gonadal sex in turn dictates phenotypic sex.",
author = "Wilson, {J. D.} and {Griffin III}, Jim and George, {F. W.}",
year = "1979",
language = "English (US)",
volume = "22",
pages = "1275--1283",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

TY - JOUR

T1 - The mechanism of phenotypic sex differentiation

AU - Wilson, J. D.

AU - Griffin III, Jim

AU - George, F. W.

PY - 1979

Y1 - 1979

N2 - For the first 2 months of gestation, there is no difference in the development of male and female embryos. Gonadal differentiation then ensues, and the ovary and testis commence to synthesize their characteristic hormones at approximately the same time. The initial secretion of testosterone by the fetal testis and 17β-estradiol by the fetal ovary appears to be independent of gonadotropin control. If an ovary or no gonad is present, the resulting phenotype is female; thus no gonadal hormones appear to be required for female development. In contrast, two secretions of the fetal testis are responsible for the imposition of the male phenotype. Mullerian regression factor, a poorly characterized peptide hormone, is responsible for suppression of the mullerian ducts, and testosterone accounts for the remainder of male development. The mechanisms by which testosterone causes this differentiative process have been deduced from studies in humans and animals of single gene mutations that interfere with androgen action. Testosterone itself is responsible for virilization of the wolffian ducts into the epididymis, vas deferens, and seminal vesicles, whereas the testosterone metabolite dihydrotestosterone induces the development of the male urethra and external genitalia. Both testosterone and dihydrotestosterone act by combining in the cell cytosol with a high affinity receptor protein that is translocated to the cell nucleus. Chromosomal sex determines gonadal sex, and gonadal sex in turn dictates phenotypic sex.

AB - For the first 2 months of gestation, there is no difference in the development of male and female embryos. Gonadal differentiation then ensues, and the ovary and testis commence to synthesize their characteristic hormones at approximately the same time. The initial secretion of testosterone by the fetal testis and 17β-estradiol by the fetal ovary appears to be independent of gonadotropin control. If an ovary or no gonad is present, the resulting phenotype is female; thus no gonadal hormones appear to be required for female development. In contrast, two secretions of the fetal testis are responsible for the imposition of the male phenotype. Mullerian regression factor, a poorly characterized peptide hormone, is responsible for suppression of the mullerian ducts, and testosterone accounts for the remainder of male development. The mechanisms by which testosterone causes this differentiative process have been deduced from studies in humans and animals of single gene mutations that interfere with androgen action. Testosterone itself is responsible for virilization of the wolffian ducts into the epididymis, vas deferens, and seminal vesicles, whereas the testosterone metabolite dihydrotestosterone induces the development of the male urethra and external genitalia. Both testosterone and dihydrotestosterone act by combining in the cell cytosol with a high affinity receptor protein that is translocated to the cell nucleus. Chromosomal sex determines gonadal sex, and gonadal sex in turn dictates phenotypic sex.

UR - http://www.scopus.com/inward/record.url?scp=0018611623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018611623&partnerID=8YFLogxK

M3 - Article

C2 - 508377

AN - SCOPUS:0018611623

VL - 22

SP - 1275

EP - 1283

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 11

ER -